Metabolism - Clinical and Experimental
Volume 44 , Pages 67-71 , October 1995

The role of growth hormone, insulin-like growth factors (IGFs), and IGF-binding proteins in experimental diabetic kidney disease

  • Allan Flyvbjerg

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Allan Flyvbjerg, MD, DSc, Institute of Experimental Clinical Research, Aarhus Kommunehospital, University of Aarhus, DK-8000 Aarhus C, Denmark.
    • Institute of Experimental Clinical Research, Aarhus Kommunehospital, Aarhus, Denmark
    • Department of Pediatricsand Nephrology, Beer-Sheva, Israel
    • Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Daniel Landau

      Affiliations

    • Institute of Experimental Clinical Research, Aarhus Kommunehospital, Aarhus, Denmark
    • Department of Pediatricsand Nephrology, Beer-Sheva, Israel
    • Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Horacio Domene

      Affiliations

    • Institute of Experimental Clinical Research, Aarhus Kommunehospital, Aarhus, Denmark
    • Department of Pediatricsand Nephrology, Beer-Sheva, Israel
    • Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Lute Hernandez

      Affiliations

    • Institute of Experimental Clinical Research, Aarhus Kommunehospital, Aarhus, Denmark
    • Department of Pediatricsand Nephrology, Beer-Sheva, Israel
    • Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Henning Grønbæk

      Affiliations

    • Institute of Experimental Clinical Research, Aarhus Kommunehospital, Aarhus, Denmark
    • Department of Pediatricsand Nephrology, Beer-Sheva, Israel
    • Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Derek LeRoith

      Affiliations

    • Institute of Experimental Clinical Research, Aarhus Kommunehospital, Aarhus, Denmark
    • Department of Pediatricsand Nephrology, Beer-Sheva, Israel
    • Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA

References 

  1. Seyer-Hansen K. Renal hypertrophy in streptozotocin diabetic rats. Clin Sci Mol Med. 1976;51:551–555
  2. Seyer-Hansen K, Hansen J, Gundersen HJG. Renal hypertrophy in experimental diabetes: A morphometric study. Diabetologia. 1980;18:501–505
  3. Østerby R, Gundersen HJG. Glomerular size and structure in diabetes mellitus. I. Early abnormalities. Diabetologia. 1975;11:225–229
  4. Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment: Kidney size and glomerular volume. Diabetologia. 1979;16:125–128
  5. Rasch R, Mogensen CE. Urinary excretion of albumin and total protein in normal and streptozotocin diabetic rats. Acta Endocrinol (Copenh). 1980;95:376–381
  6. Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment: Albumin excretion. Diabetologia. 1980;18:413–416
  7. Ross J, Goldman JK. Effect of streptozotocin-induced diabetes on kidney weight and compensatory hypertrophy in the rat. Endocrinology. 1971;88:1079–1082
  8. Seyer-Hansen K. Renal hypertrophy in experimental diabetes: Relation to severity of diabetes. Diabetologia. 1977;13:141–143
  9. Seyer-Hansen K. Renal hypertrophy in experimental diabetes: A comparison to compensatory hypertrophy. Diabetologia. 1978;14:325–328
  10. Seyer-Hansen K, Gundersen HJG, Østerby R. Acute renal hypertrophy in experimental diabetes: Lack of effect of growth hormone administration. Diabetologia. 1981;21:373–375
  11. Seyer-Hansen K. Renal hypertrophy in experimental diabetes. Kidney Int. 1983;23:643–646
  12. Ørskov H, Olsen TS, Nielsen K, et al.  Kidney lesions in rats with severe long-term alloxan diabetes. I. Influence of age, alloxan damage, and insulin administration. Diabetologia. 1965;1:172–179
  13. Olsen TS, Ørskov H, Lundbæk K. Kidney lesions in rats with severe long-term alloxan diabetes. II. Histochemical studies. In: Comparison with human diabetic glomerular lesions. ed 2. Acta Pathol Microbiol Scand. 66:1966;p. 1–12
  14. Østerby Hansen R, Lundbæk K, Ølsen TS, et al.  Kidney lesions in rats with severe long-term alloxan diabetes. Lab Invest. 1967;17:675–692
  15. Stalder G, Schmid R. Severe functional disorders of glomerular capillaries and renal hemodynamics in treated diabetes mellitus during childhood. Ann Pediatr. 1959;193:129–138
  16. Mogensen CE, Andersen MJF. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes. 1973;22:706–712
  17. Mathews LS, Enberg B, Nordstedt G. Regulation of rat growth hormone receptor gene expression. J Biol Chem. 1989;264:9905–9910
  18. Carlsson B, Billig H, Rymo L, et al.  Expression of the growth hormone binding protein messenger RNA in the liver and extrahepatic tissues in the rat: Co-expression with the growth hormone receptor. Mol Cell Endocrinol. 1990;73:R1–R6
  19. Herington AC, Ymer SI, Tiong TS. Does the serum binding protein for growth hormone have a functional role?. Acta Endocrinol (Copenh). 1991;124:14–20
  20. Bortz JD, Rotwein P, Devol D, et al.  Focal expression of insulin-like growth factor 1 in rat kidney collecting duct. J Cell Biol. 1988;107:811–819
  21. Flyvbjerg A, Bornfeldt KE, Marshall SM, et al.  Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia. 1990;33:334–338
  22. Murphy LJ, Bell GI, Frisen HG. Tissue distribution of insulin-like growth factor I and II ribonucleic acid in the adult rat. Endocrinology. 1987;120:1279–1282
  23. Hammerman MR, Miller SB. The growth hormone insulin-like growth factor axis in kidney revisited. Am J Physiol. 1993;265:F1–F14
  24. Flyvbjerg A, Marshall SM, Frystyk J, et al.  Insulin-like growth factor I in initial renal hypertrophy in potassium depleted rats. Am J Physiol. 1992;262:F1023–F1031
  25. D'Ercole JA, Stiles AD, Underwood LE. Tissue concentration of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. In: ed 2. Proc Natl Acad Sci USA. 81:1984;p. 935–939
  26. Pillion DJ, Haskell JF, Meezan E. Distinct receptors for insulin-like growth factor I in rat renal glomeruli and tubules. Am J Physiol. 1988;255:E504–E512
  27. Werner H, Shen-Orr Z, Stannard B, et al.  Experimental diabetes increases insulin-like growth factor I and II receptor concentration and gene expression in kidney. Diabetes. 1990;39:1490–1497
  28. Flyvbjerg A, Nielsen S, Sheikh MI, et al.  Luminal and basolateral uptake and receptor binding of IGF-I in rabbit renal proximal tubules. Am J Physiol. 1993;265:F624–F633
  29. Cui S, Flyvbjerg A, Nielsen S, et al.  Distribution of IGF-II/Man-6-P receptors in rat kidney: Evidence for apical localization in proximal tubule cells. Kidney Int. 1993;43:796–807
  30. Nissley SP, Kiess W, Sklar MM. The IGF-II/M6P receptor. In:  LeRoith D editors. IGFs: Molecular and Cellular Aspects. Boca Raton, FL: CRC; 1991;p. 111–150
  31. Chin E, Bondy C. Insulin-like growth factor system gene expression in the human kidney. J Clin Endocrinol Metab. 1992;75:962–968
  32. Shimasaki S, Shimonaka M, Zhang HP, et al.  Identification of five different IGFBPs from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem. 1991;266:10646–10653
  33. Shimasaki S, Gao L, Shimonaka M, et al.  Isolation and molecular cloning of IGFBP-6. Mol Endocrinol. 1991;4:1451–1458
  34. Landau D, Chin E, Bondy C, et al.  Expression of insulin-like growth factor binding proteins in the rat kidney: Effects of long-term diabetes. Endocrinology. 1995;136:1835–1842
  35. Chin E, Zhou J, Bondy C. Renal growth hormone receptor gene expression: Relationship to renal insulin-like growth factor system. Endocrinology. 1992;131:3061–3066
  36. Hochberg Z, Amit T, Youdim BH. The growth hormone binding protein as a paradigm of the erythropoietin superfamily of receptors. Cell Signal. 1991;2:85–91
  37. Tannenbaum GS. Growth hormone secretion dynamics in streptozotocin diabetes: Evidence of a role for endogenous somatostatin. Endocrinology. 1981;108:76–82
  38. Robinson ICAF, Clark RG, Carlsson LMS. Insulin, IGF-I and growth in diabetic rats. Nature. 1987;326:549; (letter)
  39. Yde H. Abnormal growth hormone response to ingestion of glucose in juvenile diabetes. Acta Med Scand. 1969;186:499–504
  40. Hansen AaP, Johansen K. Diurnal pattern of blood glucose, serum FFA, insulin, glucagon and growth hormone in normals and juvenile diabetics. Diabetologia. 1970;6:27–33
  41. Hansen AaP. Serum growth hormone patterns in juvenile diabetes. Dan Med Bull. 1972;19(suppl 1):1–36
  42. Flyvbjerg A. The role of insulin-like growth factor I in initial renal hypertrophy in experimental diabetes. In:  Flyvbjerg A,  Ørskov H,  Alberti KGMM editor. Growth Hormone and Insulin-Like Growth Factor I in Human and Experimental Diabetes. Chichester, UK: Wiley; 1993;p. 271–306
  43. Bornfeldt KE, Arnqvist HJ, Enberg B, et al.  Regulation of insulin-like growth factor I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J Endocrinol. 1989;122:651–656
  44. Landau D, Domene H, Flyvbjerg A, et al.  Differential regulation of renal cortical growth hormone (GH) receptor (GHR) and GH-binding protein (GHBP) gene expression in experimental diabetes mellitus (DM). In: The Annual Scientific Meeting of the Israeli Diabetes Association. Tel Aviv, Israel. January 17, 1995;
  45. Flyvbjerg A, Frystyk J, Østerby R, et al.  Kidney IGF-I and renal hypertrophy in GH deficient dwarf rats. Am J Physiol. 1992;262:E956–E962
  46. Flybvjerg A, Thorlacius-Ussing O, Næraa R, et al.  Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia. 1988;31:310–314
  47. Flyvbjerg A, Frystyk J, Thorlacius-Ussing O, et al.  Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia. 1989;32:261–265
  48. Bach LA, Jerums G. Effect of puberty on initial kidney growth and rise in kidney IGF-I in diabetic rats. Diabetes. 1990;39:557–562
  49. Bach LA, Cox AJ, Mendelsohn FAO, et al.  Focal induction of IGF-binding proteins in the proximal tubules of diabetic rat kidney. Diabetes. 1992;41:499–507
  50. Flyvbjerg A, Ørskov H. Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rats: Relation to severity of diabetes. Acta Endocrinol (Copenh). 1990;122:374–378
  51. Flyvbjerg A, Bornfeldt KE, Ørskov H, et al.  Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes mellitus in rats. Diabetologia. 1991;34:715–720
  52. Charlton HM, Clark RG, Robinson ICAF, et al.  Growth hormone-deficient dwarfism in the rat: A new mutation. J Endocrinol. 1988;119:51–58
  53. Bartlett JMS, Charlton HM, Robinson ICAF, et al.  Pubertal development and testicular function in the male growth hormone-deficient rat. J Endocrinol. 1990;126:193–201
  54. Grønbæk H, Bjørn SF, Østerby R, et al.  Effect of isolated GH and IGF-I deficiency on long-term renal changes and urinary albumin excretion in diabetic dwarf rats. In: Third International Symposium on Insulin-Like Growth Factors. Sydney, Australia. February 6–10, 1994;
  55. Flyvbjerg A, Marshall SM, Frystyk J, et al.  Octreotide administration in diabetic rats: Effects on kidney growth and urinary albumin excretion. Kidney Int. 1992;41:805–812
  56. Bach LA, Stevenson JL, Allen TJ, et al.  Kidney insulin-like growth factor I mRNA levels are increased in postpubertal diabetic rats. J Endocrinol. 1991;129:5–10
  57. Marshall SM, Flyvbjerg A, Frystyk J, et al.  Renal insulin-like growth factor I and growth hormone receptor binding in experimental diabetes and after unilateral nephrectomy in the rat. Diabetologia. 1991;34:632–639
  58. Flyvbjerg A, Kessler U, Kiess W. Increased kidney and liver insulin-like growth factor II/mannose-6-phosphate receptor concentration in experimental diabetes in rats. Growth Regul. 1994;4:188–193
  59. Kiess W, Kessler U, Hoeflich A, et al.  Induction of diabetes increases IGF-II/M6P receptor mRNA expression in rat kidney but not in rat lung or heart. In: Third International Symposium on Insulin-Like Growth Factors. Sydney, Australia. February 6–10, 1994;
  60. Flyvbjerg A, Kessler U, Dorka B, et al.  Transient increase in renal IGF binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia. 1992;35:589–593
  61. De Vroede MA, Tseng LY, Katsoyannis PG, et al.  Modulation of insulin-like growth factor I binding to human fibroblast monolayer cultures by insulin-like growth factor carrier proteins released to the incubation media. J Clin Invest. 1986;77:602–613
  62. Ritvos O, Ranta T, Jalkanen J. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology. 1988;122:2150–2157

PII: 0026-0495(95)90223-6

Metabolism - Clinical and Experimental
Volume 44 , Pages 67-71 , October 1995

Article Tools